Evoke Pharma (EVOK) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Evoke Pharma Highlights GIMOTI As A Leading Solution For Gastroparesis Treatment As Domperidone Supply Ends; FDA Posts Update As Mechanism To Obtain Unapproved Domperidone Expected To Lose Supply In Early 2025
BenzingaDec 19 08:43 ET
Express News | Evoke Pharma Inc: Two Patents Are Expected to Be Orange Book Listable and Expire at End of 2029
ReutersDec 3 08:31 ET
Express News | Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting Gimoti®
ReutersDec 3 08:31 ET
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET
Evoke Pharma GAAP EPS of -$0.94, Revenue of $2.65M
Seeking AlphaNov 8 00:20 ET
Evoke Pharma | 8-K: Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
SECNov 7 16:19 ET

Comments

Stock_Drift

Dec 19 10:24

Low Floats. 11:22am

$Evoke Pharma (EVOK.US)$ $Mainz Biomed (MYNZ.US)$ $Allarity Therapeutics (ALLR.US)$ $NLS Pharmaceutics (NLSP.US)$ $Gelteq (GELS.US)$ $Real Messenger (RMSG.US)$ $PMGC Holdings (ELAB.US)$ $DallasNews (DALN.US)$ $Avalon GloboCare (ALBT.US)$ $Psyence Biomedical (PBM.US)$ $XChange TEC (XHG.US)$ $Trio Petroleum (TPET.US)$ $PainReform (PRFX.US)$
📊⚡️📊

1

Aldo Brilianta

Dec 19 09:08

$Evoke Pharma (EVOK.US)$ wow

Trytosaveabit

Dec 19 07:47

Update

$Evoke Pharma (EVOK.US)$ Evoke Pharma Highlights GIMOTI As A Leading Solution For Gastroparesis Treatment As Domperidone Supply Ends; FDA Posts Update As Mechanism To Obtain Unapproved Domperidone Expected To Lose Supply In Early 2025
Benzinga· 2 mins ago
FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025
Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical office visits and related costs compared to...

1

Jaguar8

Dec 19 07:34

NEWS

$Evoke Pharma (EVOK.US)$
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Thursday, 19th December at 8:30 am
FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025
Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical office visits and related costs compared to oral metoclopramide
SOLANA BEACH, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Phar...

1

9

Jaguar8

Dec 3 16:27

🟢Watchlist Wednesday, December 4. NFA. Check on my previous watchlist. Those without ✅ means they can have delayed market reaction.

Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...

34

7

6

EVOK Evoke Pharma

Trade Overview

Capital Trend

News

Comments